Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gregory J Dore

Showing results (1-10 of 466) with videos related to

Pageof 47
Sort By:
The International Journal on Drug Policy|January 24, 2025
Monitoring hepatitis C elimination among people who inject drugs: A broader approach is requiredGregory J Dore
Addiction (Abingdon, England)|June 7, 2017
Commentary on Gountas et al. (2017): Time to focus on empirical evidence for HCV treatment as preventionGregory J Dore
The AIDS Reader|July 31, 2004
Editorial comment: triple infection with HIV and hepatitis B and C viruses--lesson in combination therapyGregory J Dore
The Medical Journal of Australia|June 9, 2012
The changing therapeutic landscape for hepatitis CGregory J Dore
Hepatology (Baltimore, Md.)|August 18, 2016
Hepatitis C treatment as prevention among HIV-infected men who have sex with men: Feasible?Gregory J Dore
Hepatology (Baltimore, Md.)|December 26, 2006
Enhancing hepatitis C treatment uptake and outcomes for injection drug usersGregory J Dore
Australian Prescriber|April 29, 2021
Elimination of hepatitis C in Australia by 2030: a decade and countingGregory J Dore
Journal of Viral Hepatitis|February 26, 2019
HCV reinfection as a positive indication of high-risk population treatment accessGregory J Dore
The Lancet. Gastroenterology & Hepatology|April 13, 2018
Striving for hepatitis C virus elimination or control?Gregory J Dore
Clinical Liver Disease|April 18, 2019
Treatment of HCV in persons who inject drugs: Treatment as preventionJason Grebely, Gregory J Dore
Pageof 47

Showing results (1-10 of 466) with videos related to

Sort By:
Pageof 47
The International Journal on Drug Policy|January 24, 2025
Monitoring hepatitis C elimination among people who inject drugs: A broader approach is requiredGregory J Dore
Addiction (Abingdon, England)|June 7, 2017
Commentary on Gountas et al. (2017): Time to focus on empirical evidence for HCV treatment as preventionGregory J Dore
The AIDS Reader|July 31, 2004
Editorial comment: triple infection with HIV and hepatitis B and C viruses--lesson in combination therapyGregory J Dore
The Medical Journal of Australia|June 9, 2012
The changing therapeutic landscape for hepatitis CGregory J Dore
Hepatology (Baltimore, Md.)|August 18, 2016
Hepatitis C treatment as prevention among HIV-infected men who have sex with men: Feasible?Gregory J Dore
Hepatology (Baltimore, Md.)|December 26, 2006
Enhancing hepatitis C treatment uptake and outcomes for injection drug usersGregory J Dore
Australian Prescriber|April 29, 2021
Elimination of hepatitis C in Australia by 2030: a decade and countingGregory J Dore
Journal of Viral Hepatitis|February 26, 2019
HCV reinfection as a positive indication of high-risk population treatment accessGregory J Dore
The Lancet. Gastroenterology & Hepatology|April 13, 2018
Striving for hepatitis C virus elimination or control?Gregory J Dore
Clinical Liver Disease|April 18, 2019
Treatment of HCV in persons who inject drugs: Treatment as preventionJason Grebely, Gregory J Dore
Pageof 47